Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of economic models in randomized clinical trials (Q33603860)

28 July 2017

1 reference

title

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Role of economic models in randomized clinical trials (English)

1 reference

28 July 2017

1

Hlatky MA

2 references

ORCID Public Data File 2021

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

28 July 2017

published in

American Heart Journal

1 reference

28 July 2017

volume

137

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

S41-6

1 reference

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Benefit-cost analysis of rubella vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

An Analysis of the Cost-Effectiveness of Pharyngitis Management and Acute Rheumatic Fever Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

The journal's policy on cost-effectiveness analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Economic analysis and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Economic analysis in randomized control trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

The clinical-economic trial: promise, problems, and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Costs, effects and C/E-ratios alongside a clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Confidence intervals for cost-effectiveness ratios.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Confidence intervals for cost/effectiveness ratios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Use of confidence intervals and sample size calculations in health economic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Statistical data analysis in the computer age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Long-term cost-effectiveness of alternative management strategies for patients with life-threatening ventricular arrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

The relationship between coronary angioplasty procedure volume and major complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Coronary angioplasty volume-outcome relationships for hospitals and cardiologists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Outcome of Acute Myocardial Infarction According to the Specialty of the Admitting Physician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970427-8

10.1016/S0002-8703(99)70427-8

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference